Lilly Flags Safety Risk in Compounded Zepbound Mixed With Vitamin B12
Insurance Journal - Mar 12, 2026
Eli Lilly & Co. warned that the active ingredient in its weight-loss blockbuster Zepbound could pose a risk to patients when mixed with vitamin B12, a combination sold by US drug compounders. Lilly tested compounded products and found “significant levels …...
Recommended Articles
Posted: Mar 12, 2026
It’s becoming increasingly evident that Iran is laying mines in the Strait of Hormuz, accordin...
Posted: Mar 12, 2026
A North Carolina insurance agent is out on bond, awaiting court action, after he was charged with di...
Posted: Mar 12, 2026
Marsh Risk, a business of Marsh, and specialty insurer Apollo’s ibott division announced the l...